Rasmy A, Amal A FS and SW. Febrile Neutropenia in Cancer Patient: Epidemiology, Microbiology, Pathophysiology and Management. J Cancer Prev Curr Res. 2016;5(3). http://medcraveonline.com/JCPCR/JCPCR-05-00165.php

Lyman GH, Michels SL, Reynolds MW, Barron R, Tomic KS, Yu J. Risk of mortality in patients with cancer who experience febrile neutropenia. Cancer. 2010;116(23):5555–63. https://doi.org/10.1002/cncr.25332.

Article  PubMed  Google Scholar 

Mikulska GG. Bloodstream infections in neutropenic cancer patients: a practical update. Virulence. 2016;7(3):280–97.

Article  PubMed  PubMed Central  Google Scholar 

Tohamy ST, Aboshanab KM, El-Mahallawy HA, El-Ansary MR, Afifi SS. Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations. Infect Drug Resist. 2018;11:791–803.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carmona-Bayonas A, Jiménez-Fonseca P, Echaburu JV, Antonio M, Font C, Biosca M, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: Validation of the clinical index of stable febrile neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol. 2015;33(5):465–71. https://doi.org/10.1200/JCO.2014.57.2347.

Article  PubMed  Google Scholar 

Kazaura MR, Kombe D, Yuma S, Mtiro H, Mlawa G. Health seeking behavior among cancer patients attending Ocean Road Cancer Institute, Tanzania. East Afr J Public Health. 2007;4(1):19–22.

PubMed  Google Scholar 

Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Ogweyo P, Eissa MS, et al. Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Dis. 2010;31(1):33–41.

Article  PubMed  PubMed Central  Google Scholar 

Moshi FV, Vandervort EB, Kibusi SM. Cervical cancer awareness among women in Tanzania: an analysis of data from the 2011–12 Tanzania HIV and Malaria indicators survey. Int J Chronic Dis. 2018;2018:1–7.

Article  Google Scholar 

Ng’ida FD, Kotoroi GL, Mwangi R, Mabelele MM, Kitau J, Mahande MJ. Knowledge and practices on breast cancer detection and associated challenges among women aged 35 years and above in Tanzania: a case in Morogoro rural district. Breast Cancer Targets Ther. 2019;11:191–7.

Article  Google Scholar 

Runge AS, Bernstein ME, Lucas AN, Tewari KS. Cervical cancer in Tanzania: A systematic review of current challenges in six domains. Vol. 29, Gynecologic Oncology Reports. Elsevier; 2019. p. 40–7.

Vrinten C, Gallagher A, Waller J, Marlow LAV. Cancer stigma and cancer screening attendance: a population based survey in England. BMC Cancer. 2019;19(1):1–10.

Article  Google Scholar 

Louw V, van der Westhuizen J, Rautenbach W, van der Berg E, Wamelink M, Joubert G. The antibiotic susceptibility of bacteria isolated from blood cultures during episodes of neutropenic fever in patients with acute myeloid leukaemia. S Afr J Epidemiol Infect. 2010;25(2):9–11.

Google Scholar 

Pettengell R, Bosly A, Szucs TD, Jackisch C, Leonard R, Paridaens R, et al. Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy. Anticancer Drugs. 2009;4(4):1054–60. https://doi.org/10.1086/383048.

Article  Google Scholar 

Maertens J, Georgala A, Rolston K, Paesmans M, Rapoport B, Ferrant A, et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents. 2007;30:51–9.

Article  Google Scholar 

Hashiguchi Y, Kasai M, Fukuda T, Ichimura T, Yasui T, Sumi T. Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy. Anticancer Drugs. 2015;26(10):1054–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moghnieh R, Estaitieh N, Mugharbil A, Jisr T, Abdallah DI, Ziade F, et al. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation w. Front Cell Infect Microbiol. 2015;5:11. https://doi.org/10.3389/fcimb.2015.00011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lalami Y, Klastersky J. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data. Vol. 120, Critical Reviews in Oncology/Hematology. 2017. p. 163–79. https://linkinghub.elsevier.com/retrieve/pii/S104084281730313X

Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35(18):2082–94. https://doi.org/10.1200/JCO.2016.71.7017.

Article  CAS  PubMed  Google Scholar 

Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. IDSA Guidel. 2002;34:203–8.

Google Scholar 

Dellit TH, Owens RC, Mcgowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious diseases society of American and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.

Article  PubMed  Google Scholar 

Song S, Vuai MS, Zhong M. The role of bacteria in cancer therapy - Enemies in the past, but allies at present. Vol. 13, Infectious Agents and Cancer. BioMed Central; 2018. p. 9. https://doi.org/10.1186/s13027-018-0180-y

Bodro M, Gudiol C, Garcia-Vidal C, Tubau F, Contra A, Boix L, et al. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients. Support Care Cancer. 2014;22(3):603–10. https://doi.org/10.1007/s00520-013-2012-3.

Article  PubMed  Google Scholar 

Irfan S, Idrees F, Mehraj V, Habib F, Adil S, Hasan R. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect Dis. 2008;8(1):80. https://doi.org/10.1186/1471-2334-8-80.

Article  PubMed  PubMed Central  Google Scholar 

Kim HS, Lee SY, Kim JW, Choi YJ, Park IH, Lee KS, et al. Incidence and predictors of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy in Korea. Oncol. 2016;91(5):274–82.

Article  CAS  Google Scholar 

Lakhe NA, Sylla K, Mbaye KD, Ndiaye R, Marie V, Cisse P, et al. Bacteremia: Profile and antibiotic resistance at the infectious and tropical diseases clinic in Fann Hospital, Dakar. Senegal J Infect Dis Ther. 2018;6(1):1–8.

Google Scholar 

Ibrahim TM, Pang C. Bacteremia pattern in febrile neutropenia among adults cancer patients receiving chemotherapy in an Australia Regional Hospital. Univers J Public Heal. 2017;5(4):172–5.

Article  Google Scholar 

Moremi N, Claus H, Mshana SE. Antimicrobial resistance pattern: A report of microbiological cultures at a tertiary hospital in Tanzania. Vol. 16, BMC Infectious Diseases. 2016. p. 756. https://doi.org/10.1186/s12879-016-2082-1

Meidani M, Bagheri A, Khorvash F. A population-based study of bacterial spectrum in febrile neutropenic patients. Jundishapur J Microbiol. 2013;6(2):150–6.

Article  Google Scholar 

Onken A, Said AK, Jørstad M, Jenum PA, Blomberg B. Prevalence and antimicrobial resistance of microbes causing bloodstream infections in unguja, Zanzibar. PLoS ONE. 2015;10(12):e0145632. https://doi.org/10.1371/journal.pone.0145632.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dias P, Lakshika S, Lenaduwe A. Risk factors for Bacteraemia in Cancer Patients Contributors: 1. Sonali Lenaduwe 1, BSc (Hons) in Medical Laboratory Sciences, Demonstrator, Faculty of Allied Health Sciences, General Sir John Kotelawala Defence University, Sri Lanka. 2. Achini Sandunika. bioRxiv. 2018;386193. https://doi.org/10.1101/386193v3.abstract

Herrera PCMDJPCMLGIPVCJPVPMLARFP and F. Multidrug-resistant Gram-negative Bacteremia in Cancer Patients: Development of a Clinical Score for Risk Assessment. 2017;4(Suppl 1):2017.

Herrera F, Laborde A, Rossi IR, Guerrini G, Jordan R, Valledor A, et al. Prognostic factors for 7-day and 30-day mortality during gram-negative bacteremia episodes in cancer and hematopoietic stem cell transplant patients. Int J Infect Dis. 2018;73:3.

Article  Google Scholar 

Mushtaq A, Bredell BX, Soubani AO. Repeating blood cultures after initial bacteremia: when and how often? Cleve Clin J Med. 2019;86(2):89–92.

Article  PubMed  Google Scholar 

Tabriz MS, Riederer K, Baran J, Khatib R. Repeating blood cultures during hospital stay: practice pattern at a teaching hospital and a proposal for guidelines. Clin Microbiol Infect. 2004;10(7):624–7.

Article  CAS  PubMed  Google Scholar 

Lambregts MMC, Warreman EB, Bernards AT, Veelken H, von dem Borne PA, Dekkers OM, et al. Distribution and clinical determinants of time-to-positivity of blood cultures in patients with neutropenia. Eur J Haematol. 2018;100(2):206–14. https://doi.org/10.1111/ejh.13001.

Article  CAS  PubMed  Google Scholar 

Wiggers JB, Xiong W, Daneman N. Sending repeat cultures: Is there a role in the management of bacteremic episodes? (SCRIBE study). BMC Infect Dis. 2016;16(1):1–10.

Article  Google Scholar 

Lubwama M, Phipps W, Najjuka CF, Kajumbula H, Ddungu H, Kambugu JB, et al. Bacteremia in febrile cancer patients in Uganda. BMC Res Notes. 2019;12(1):464. https://doi.org/10.1186/s13104-019-4520-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis. 2004;39(s1):S25-31. https://doi.org/10.1086/383048.

Article  PubMed  Google Scholar 

Rolston KVI. Bacterial infection in neutropenic cancer patients: an overview. Iran J Clin Infect Dis. 2009;4(2):115–22.

Google Scholar 

Prabahar K, Dinesh S, Barla S. Antibiotics utilization pattern in pediatrics. Asian J Pharm. 2017;2017(1):230–4.

Google Scholar 

Rather IA, Kim BC, Bajpai VK, Park YH. Self-medication and antibiotic resistance: Crisis, current challenges, and prevention. Vol. 24, Saudi Journal of Biological Sciences. 2017. p. 808–12.

Obeng-Nkrumah N, Labi A-K, Acquah ME, Donkor ES. Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting. BMC Res Notes. 2015;8(1):742.

Article  PubMed  PubMed Central  Google Scholar 

El-mahallawy HA, Shawky S, El-wakil M. Bacteremia due to ESKAPE pathogens: an emerging problem in cancer patients. J Egypt Natl Canc Inst. 2016;28(3):157–62. https://doi.org/10.1016/j.jnci.2016.05.002.

Article  PubMed  Google Scholar 

Santajit S, Indrawattana N. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. Vol. 2016, BioMed Research International. 2016.

Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis. 2004;39(s1):S32–7. https://doi.org/10.1086/383050.

Article  PubMed  Google Scholar 

Rattinger GB, Mullins CD, Zuckerman IH, Onukwugha E, Walker LD, Gundlapalli A, et al. A Sustainable Strategy to Prevent Misuse of Antibiotics for Acute Respiratory Infections. PLoS ONE. 2012;7(12):e51147.

Article